1. Esteatosis hepática asociada a la severidad de la neumonía por COVID-19 por tomografía.
- Author
-
Ramírez-Urrutia, Luis A., Gutiérrez-Cruz, Edith, Rodríguez-Palomares, Luis A., and Figueroa-García, Juan
- Abstract
Objective: To determine the prevalence of hepatic steatosis and whether there is an association with pulmonary involvement in CT scans of patients with COVID-19. Material and methods: 140 patients with positive PCR for SARS-CoV-2 and with simple chest tomography were evaluated. The tomographic findings of COVID-19 were evaluated by the CO-RADS system, pulmonary involvement was classified with the proposed INER scale and hepatic steatosis was determined at 42 UH. The SPSS program was used for statistical analysis with X2 test. Results: Out of 140 patients we found 91 men (65%) and 49 women (65%). The most affected age was 60.9 ± 15 years. The prevalence of hepatic steatosis was 32.1%, no association was found with the degree of pulmonary involvement by X2 test (p = 0.151). Obesity was observed in 37.1%, overweight in 36.4%, arterial hypertension in 35.7% and diabetes mellitus in 21.8%. Conclusions: There is no association between hepatic steatosis and pulmonary involvement in COVID-19 pneumonia. The prevalence of hepatic steatosis of 32.1% is similar to that reported in other studies. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF